These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17827369)

  • 21. A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune.
    Angel JB; Routy JP; Tremblay C; Ayers D; Woods R; Singer J; Bernard N; Kovacs C; Smaill F; Gurunathan S; Sekaly RP
    AIDS; 2011 Mar; 25(6):731-9. PubMed ID: 21330911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the serotonin receptor agonist, buspirone, on immune function in HIV-infected individuals: a six-month randomized, double-blind, placebo-controlled trial.
    Eugen-Olsen J; Benfield T; Axen TE; Parner J; Iversen J; Pedersen C; Nielsen JO
    HIV Clin Trials; 2000; 1(1):20-6. PubMed ID: 11590486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wuchereria bancrofti antigenemia clearance among Myanmar migrants after biannual mass treatments with diethylcarbamazine, 300 mg oral-dose FILADEC tablet, in Southern Thailand.
    Koyadun S; Bhumiratana A; Prikchu P
    Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):758-67. PubMed ID: 15115084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of TT virus in HIV-1 exposed but uninfected individuals and in HIV-1 infected patients and its influence on CD4+ lymphocytes and viral load.
    Nasser TF; Brajão de Oliveira K; Reiche EM; Amarante MK; Pelegrinelli Fungaro MH; Watanabe MA
    Microb Pathog; 2009 Jul; 47(1):33-7. PubMed ID: 19409976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?
    McCarthy J
    Am J Trop Med Hyg; 2005 Aug; 73(2):232-3. PubMed ID: 16103580
    [No Abstract]   [Full Text] [Related]  

  • 26. [T cell receptor diversity of CD8+ T lymphocytes and its association with viral load in individuals with HIV-1 infection].
    Ren GL; Chen JP; Jia MM; Kou ZC; Liu S; Ma PF; Shao YM; Hong KX
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 May; 43(5):404-8. PubMed ID: 19534995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
    Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
    J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comment on: co-infection with subclinical HIV and Wuchereria bancrofti, and the role of malaria and hookworms, in adult Tanzanians: infection intensities, CD4/CD8 counts and cytokine responses.
    Eisenhut M
    Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):204-5; discussion 205-6. PubMed ID: 17945321
    [No Abstract]   [Full Text] [Related]  

  • 29. A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis.
    Elliott AM; Luzze H; Quigley MA; Nakiyingi JS; Kyaligonza S; Namujju PB; Ducar C; Ellner JJ; Whitworth JA; Mugerwa R; Johnson JL; Okwera A
    J Infect Dis; 2004 Sep; 190(5):869-78. PubMed ID: 15295690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of immune parameters before treatment interruption (TI) for CD4+ T-cell count change during TI in HIV infection.
    Huang KH; Loutfy MR; Boulet S; Toma E; Tsoukas CM; Bernard NF
    Antivir Ther; 2009; 14(3):381-92. PubMed ID: 19474472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunologic features of HIV-1-infected women on HAART at delivery.
    Ono E; Dos Santos AM; Machado DM; Succi RC; Amed AM; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2008 Jul; 74(4):236-43. PubMed ID: 18393385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis.
    Ramaiah KD; Das PK; Vanamail P; Pani SP
    Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):555-63. PubMed ID: 17374389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection.
    van den Berg CH; Ruys TA; Nanlohy NM; Geerlings SE; van der Meer JT; Mulder JW; Lange JA; van Baarle D
    J Viral Hepat; 2009 Apr; 16(4):239-48. PubMed ID: 19222746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
    Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
    Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of two annual, single-dose mass drug administrations of diethylcarbamazine alone or in combination with albendazole on soil-transmitted helminthiasis in filariasis elimination programme.
    Mani TR; Rajendran R; Sunish IP; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP
    Trop Med Int Health; 2004 Sep; 9(9):1030-5. PubMed ID: 15361118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase in natural killer cell activity during diethylcarbamazine treatment of patients with filariasis.
    Pedersen BK; Bygbjerg IC; Svenson M
    Acta Trop; 1987 Sep; 44(3):353-5. PubMed ID: 2892372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes.
    Kloverpris H; Karlsson I; Bonde J; Thorn M; Vinner L; Pedersen AE; Hentze JL; Andresen BS; Svane IM; Gerstoft J; Kronborg G; Fomsgaard A
    AIDS; 2009 Jul; 23(11):1329-40. PubMed ID: 19528789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial.
    Taylor MJ; Makunde WH; McGarry HF; Turner JD; Mand S; Hoerauf A
    Lancet; 2005 Jun 18-24; 365(9477):2116-21. PubMed ID: 15964448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of a single-dose treatment with 300 mg diethylcarbamazine and a combination of 400 mg albendazole in reduction of Wuchereria bancrofti antigenemia and concomitant geohelminths in Myanmar migrants in Southern Thailand.
    Yongyuth P; Koyadun S; Jaturabundit N; Sampuch A; Bhumiratana A
    J Med Assoc Thai; 2006 Aug; 89(8):1237-48. PubMed ID: 17048435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of single dose of diethylcarbamazine and other antifilarial drug combinations on bancroftian filarial infection variables: assessment after 2 years.
    Sunish IP; Rajendran R; Mani TR; Munirathinam A; Reuben R; Dash AP
    Parasitol Int; 2006 Sep; 55(3):233-6. PubMed ID: 16807079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.